Description
Androcur™, manufactured by Bayer, utilizes Cyproterone acetate to competitively block androgen receptors throughout the body. In men, it lowers serum testosterone levels, serving as an effective palliative treatment for advanced prostate carcinoma. In women, it helps counter the systemic effects of excessive androgen production, relieving severe hirsutism (excessive facial or body hair growth), androgenic alopecia, and severe cystic acne.
Trusted Pharmaceutical Standard The 50 mg strength offers a precise clinical dosage for specialized endocrine and oncological therapy. Packaged in a 5×10 tabs layout (50 oral tablets), Androcur ensures convenient, long-term daily routine tracking. Manufactured to global quality standards by Bayer, this oral formulation provides a dependable option for targeted hormonal management.
Reviews
There are no reviews yet.